Sensus Healthcare, Inc. (SRTS) stock
SRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/3043% below fair value
$2.33−0.90 (-27.80%)
Close on Nov 13, 2026Market cap $38.27MP/E –Yield –
Sensus Healthcare price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Sensus Healthcare's price to sales ratio was 3.2× on Nov 11, 2026, against 1.9× a year earlier. Over the last 5 years it ranged from 1.2× to 6.7×, with a median of 2.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.2× | +1.4 |
| 2025 | Dec 31, 2025 | 1.8× | −0.9 |
| 2024 | Dec 31, 2024 | 2.7× | +1.2 |
| 2023 | Dec 29, 2023 | 1.6× | −1.2 |
| 2022 | Dec 30, 2022 | 2.8× | −3.5 |
| 2021 | Dec 31, 2021 | 6.3× | +1.4 |
| 2020 | Dec 31, 2020 | 4.9× | +2.7 |
| 2019 | Dec 31, 2019 | 2.2× | −2.6 |
| 2018 | Dec 31, 2018 | 4.8× | +1.1 |
| 2017 | Dec 29, 2017 | 3.7× | −1.5 |
| 2016 | Dec 30, 2016 | 5.2× | – |
See a number that looks wrong?